Tag Archives: Blood pressure

Feds Threaten to Pull ProAmatine for Lack of Postmarket Data (Updated 8/18)

Image via Wikipedia FDA on Monday announced that it was looking to withdraw approval for the low-blood-pressure treatment midodrine hydrochloride because the companies manufacturing the drug failed to provide data from post-approval studies. The kicker: The drug was approved 14 years ago. FDA gave midodrine hydrochloride—branded by Shire as ProAmatine and produced by a half-dozen […]
Posted in FDA | Also tagged , , , , , , , | 1 Comment

Strategic Patient Adherence Awards: “And the Winners Are”

Pharm Exec was proud to partner this year with CBI on the eighth annual Forum on Patient Compliance, Adherence & Persistency. One of the highlights of the event is the presentation of the Strategic Patient Adherence Awards, which honor pharma-based programs to improve compliance. The winners this year: For best branded program AstraZeneca Canada for […]
Posted in Events | Also tagged , , , , , , | Leave a comment
  • Categories

  • Meta